Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Head and Neck Neoplasms 3Breast Neoplasms 3Hot Flashes 2Vomiting 1Urinary Bladder Neoplasms 1Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pain, Postoperative 1Pain 1Oropharyngeal Neoplasms 1Neuralgia 1Neoplasms 1Nausea 1Mucositis 1Lung Neoplasms 1Laryngeal Diseases 1Acute Pain 1Abnormalities, Radiation-Induced 1

Interventions

Gemcitabine 57Paclitaxel 50Cyclophosphamide 45pembrolizumab 44Carboplatin 41Bevacizumab 38Cisplatin 33Docetaxel 31Fluorouracil 30Nivolumab 29Capecitabine 29Pemetrexed 24Irinotecan 24Oxaliplatin 23Dexamethasone 23Ipilimumab 22Leucovorin 21Radiotherapy 20Sorafenib 19Doxorubicin 19Everolimus 18Cetuximab 18fludarabine 17Albumin-Bound Paclitaxel 17trametinib 15Sunitinib 15Rituximab 15Erlotinib Hydrochloride 15130-nm albumin-bound paclitaxel 15Prednisone 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Neoplasms × Gabapentin × Clear all
NCT03682367 2021-07-09

Perioperative Analgesia Using Gabapentin in Head and Neck Cancer Surgery

University of California, Davis

Phase 3 Terminated
8 enrolled 6 charts
Head & Neck

Head and Neck Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡